Trials / Completed
CompletedNCT01174823
Safety and Efficacy of Bepotastine Besilate Ophthalmic Solution in Seasonal Allergic Conjunctivitis Patients
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 245 (actual)
- Sponsor
- Bausch & Lomb Incorporated · Industry
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to study the safety and efficacy of bepotastine besilate ophthalmic solution in allergic conjunctivitis patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | bepotastine besilate ophthalmic solution | sterile ophthalmic solution |
| DRUG | placebo comparator ophthalmic solution | sterile ophthalmic solution |
Timeline
- Start date
- 2010-06-01
- Primary completion
- 2010-10-01
- Completion
- 2010-12-01
- First posted
- 2010-08-04
- Last updated
- 2020-09-14
- Results posted
- 2020-09-14
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01174823. Inclusion in this directory is not an endorsement.